191 related articles for article (PubMed ID: 30423315)
1. Genome-wide DNA methylation assessment of 'BRCA1-like' early-onset breast cancer: Data from the Australian Breast Cancer Family Registry.
Scott CM; Wong EM; Joo JE; Dugué PA; Jung CH; O'Callaghan N; Dowty J; Giles GG; Hopper JL; Southey MC
Exp Mol Pathol; 2018 Dec; 105(3):404-410. PubMed ID: 30423315
[TBL] [Abstract][Full Text] [Related]
2. Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.
Scott CM; Joo JE; O'Callaghan N; Buchanan DD; Clendenning M; Giles GG; Hopper JL; Wong EM; Southey MC
PLoS One; 2016; 11(11):e0165436. PubMed ID: 27902704
[TBL] [Abstract][Full Text] [Related]
3. Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.
Wong EM; Southey MC; Fox SB; Brown MA; Dowty JG; Jenkins MA; Giles GG; Hopper JL; Dobrovic A
Cancer Prev Res (Phila); 2011 Jan; 4(1):23-33. PubMed ID: 20978112
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer.
Gupta S; Jaworska-Bieniek K; Narod SA; Lubinski J; Wojdacz TK; Jakubowska A
Breast Cancer Res Treat; 2014 Dec; 148(3):615-22. PubMed ID: 25376744
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype.
Snell C; Krypuy M; Wong EM; ; Loughrey MB; Dobrovic A
Breast Cancer Res; 2008; 10(1):R12. PubMed ID: 18269736
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.
Iwamoto T; Yamamoto N; Taguchi T; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2011 Aug; 129(1):69-77. PubMed ID: 20882403
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307
[TBL] [Abstract][Full Text] [Related]
8. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
Brianese RC; Nakamura KDM; Almeida FGDSR; Ramalho RF; Barros BDF; Ferreira ENE; Formiga MNDC; de Andrade VP; de Lima VCC; Carraro DM
Breast Cancer Res Treat; 2018 Feb; 167(3):803-814. PubMed ID: 29116469
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the BRCAness phenotype and its correlations with clinicopathological features in triple-negative breast cancers.
Tian T; Shan L; Yang W; Zhou X; Shui R
Hum Pathol; 2019 Feb; 84():231-238. PubMed ID: 30339969
[TBL] [Abstract][Full Text] [Related]
11. Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and "BRCA-Like" Status, in Both Blood and Tumour DNA.
Daniels SL; Burghel GJ; Chambers P; Al-Baba S; Connley DD; Brock IW; Cramp HE; Dotsenko O; Wilks O; Wyld L; Cross SS; Cox A
PLoS One; 2016; 11(7):e0160174. PubMed ID: 27463681
[TBL] [Abstract][Full Text] [Related]
12. Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry.
Smith LD; Tesoriero AA; Wong EM; Ramus SJ; O'Malley FP; Mulligan AM; Terry MB; Senie RT; Santella RM; John EM; Andrulis IL; Ozcelik H; Daly MB; Godwin AK; Buys SS; Fox S; Goldgar DE; Giles GG; Hopper JL; Southey MC
Breast Cancer Res; 2011 Jan; 13(1):R14. PubMed ID: 21281505
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer.
Felicio PS; Melendez ME; Arantes LM; Kerr LM; Carraro DM; Grasel RS; Campacci N; Scapulatempo-Neto C; Fernandes GC; de Carvalho AC; Palmero EI
Oncotarget; 2017 Jan; 8(2):2850-2862. PubMed ID: 27926510
[TBL] [Abstract][Full Text] [Related]
14. Tools for translational epigenetic studies involving formalin-fixed paraffin-embedded human tissue: applying the Infinium HumanMethyation450 Beadchip assay to large population-based studies.
Wong EM; Joo JE; McLean CA; Baglietto L; English DR; Severi G; Hopper JL; Milne RL; FitzGerald LM; Giles GG; Southey MC
BMC Res Notes; 2015 Oct; 8():543. PubMed ID: 26438025
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes in BRCA1-mutated familial breast cancer.
Downs B; Wang SM
Cancer Genet; 2015 May; 208(5):237-40. PubMed ID: 25800897
[TBL] [Abstract][Full Text] [Related]
16. Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.
Hsu NC; Huang YF; Yokoyama KK; Chu PY; Chen FM; Hou MF
PLoS One; 2013; 8(2):e56256. PubMed ID: 23405268
[TBL] [Abstract][Full Text] [Related]
17. Association of BRCA1 Promoter Methylation with Breast Cancer in Asia: A Meta- Analysis.
Nindrea RD; Harahap WA; Aryandono T; Lazuardi L
Asian Pac J Cancer Prev; 2018 Apr; 19(4):885-889. PubMed ID: 29693332
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics.
Catteau A; Harris WH; Xu CF; Solomon E
Oncogene; 1999 Mar; 18(11):1957-65. PubMed ID: 10208417
[TBL] [Abstract][Full Text] [Related]
19. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
20. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]